Compare NNNN & PLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNNN | PLAB |
|---|---|---|
| Founded | 2021 | 1969 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | 2025 | 1987 |
| Metric | NNNN | PLAB |
|---|---|---|
| Price | $26.06 | $36.26 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $43.50 |
| AVG Volume (30 Days) | 26.9K | ★ 1.8M |
| Earning Date | 04-28-2026 | 12-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 9.09 |
| EPS | 0.06 | ★ 2.28 |
| Revenue | $8,185,146.00 | ★ $849,294,000.00 |
| Revenue This Year | N/A | $4.63 |
| Revenue Next Year | N/A | $6.20 |
| P/E Ratio | $534.57 | ★ $15.93 |
| Revenue Growth | ★ 21.95 | N/A |
| 52 Week Low | $5.18 | $16.46 |
| 52 Week High | $55.65 | $39.80 |
| Indicator | NNNN | PLAB |
|---|---|---|
| Relative Strength Index (RSI) | 46.07 | 78.27 |
| Support Level | $26.89 | $35.69 |
| Resistance Level | $44.73 | $39.80 |
| Average True Range (ATR) | 5.72 | 1.61 |
| MACD | -0.32 | 1.67 |
| Stochastic Oscillator | 22.84 | 80.07 |
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
Photronics Inc is a U.S.-based company that is principally engaged in manufacturing photomasks. The photomasks are photographic quartz or glass plates that contain microscopic images of electronic circuits that are used as a component in the manufacture of integrated circuits and flat-panel displays. The revenue from products designed for integrated circuits production accounts for the majority of total revenue, with the rest derived from products for flat-panel display production. The company's assets are located in Taiwan, Korea, and the United States. It generates revenue world-wide, including in the United States, Europe, Taiwan, Korea, China, and elsewhere in Asia, with Taiwan contributing the majority of total revenue.